U R Kleeberg - JoVE Visualize

Showing results (11-20 of 39) with videos related to

Pageof 4

Sort By:

Melanoma Research|February 1, 1995

Twenty-five years of pluridisciplinary approach for melanoma patients. The European Organization on Research and Treatment of Cancer Melanoma Cooperative Group (EORTC-MCG)U R Kleeberg, A M Eggermont

Leukemia Research|January 1, 1985

Low-dose cytarabine: chromosomal findings suggesting its cytostatic as well as differentiating effectD K Hossfeld, H J Weh, U R Kleeberg

Zeitschrift Fur Gastroenterologie|February 9, 2005

Health economic analysis of fluoropyrimidine-based therapies of colorectal cancer from the perspective of statutory sickness fundsA Grothey, U R Kleeberg, M Stauch, et al.

Onkologie|December 1, 1984

[Prognostic value of serum CEA and therapy-induced nonspecific CEA levels in metastasizing breast carcinoma]J Treidler, R Pompecki, U Müllerleile, et al.

Anticancer Research|July 1, 1989

Alteration of melanoma cell phenotype following in vitro culturing and exposure to cytostatic agentsE Engel, U R Kleeberg, M Dietel, et al.

European Journal of Cancer & Clinical Oncology|August 1, 1982

N-(phosphonacetyl)-L-aspartate (PALA) in advanced malignant melanoma: a phase II trial of the EORTC Malignant Melanoma Cooperative GroupU R Kleeberg, J H Mulder, P Rümke, et al.

Onkologie|February 1, 1984

[Monitoring of heart function in the treatment with cardiotoxic cytostatic drugs]H P Richter von Arnauld, U R Kleeberg, C Hassel, et al.

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 25, 2005

Patient satisfaction and quality of life in cancer outpatients: results of the PASQOC studyU R Kleeberg, J-T Tews, T Ruprecht, et al.

Onkologie|August 1, 1982

[Monitoring of Myocardial function during therapy with cardiotoxic cytostatics. Studies with the example of anthracycline-containing chemotherapy]H P Richter-v Arnauld, U R Kleeberg, C Hassel, et al.

Journal of Cancer Research and Clinical Oncology|January 1, 1988

Phase I study of pirarubicinA A Miller, M E Scheulen, U R Kleeberg, et al.

Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:

Pageof 4

Melanoma Research|February 1, 1995

Twenty-five years of pluridisciplinary approach for melanoma patients. The European Organization on Research and Treatment of Cancer Melanoma Cooperative Group (EORTC-MCG)U R Kleeberg, A M Eggermont

Leukemia Research|January 1, 1985

Low-dose cytarabine: chromosomal findings suggesting its cytostatic as well as differentiating effectD K Hossfeld, H J Weh, U R Kleeberg

Zeitschrift Fur Gastroenterologie|February 9, 2005

Health economic analysis of fluoropyrimidine-based therapies of colorectal cancer from the perspective of statutory sickness fundsA Grothey, U R Kleeberg, M Stauch, et al.

Onkologie|December 1, 1984

[Prognostic value of serum CEA and therapy-induced nonspecific CEA levels in metastasizing breast carcinoma]J Treidler, R Pompecki, U Müllerleile, et al.

Anticancer Research|July 1, 1989

Alteration of melanoma cell phenotype following in vitro culturing and exposure to cytostatic agentsE Engel, U R Kleeberg, M Dietel, et al.

European Journal of Cancer & Clinical Oncology|August 1, 1982

N-(phosphonacetyl)-L-aspartate (PALA) in advanced malignant melanoma: a phase II trial of the EORTC Malignant Melanoma Cooperative GroupU R Kleeberg, J H Mulder, P Rümke, et al.

Onkologie|February 1, 1984

[Monitoring of heart function in the treatment with cardiotoxic cytostatic drugs]H P Richter von Arnauld, U R Kleeberg, C Hassel, et al.

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 25, 2005

Patient satisfaction and quality of life in cancer outpatients: results of the PASQOC studyU R Kleeberg, J-T Tews, T Ruprecht, et al.

Onkologie|August 1, 1982

[Monitoring of Myocardial function during therapy with cardiotoxic cytostatics. Studies with the example of anthracycline-containing chemotherapy]H P Richter-v Arnauld, U R Kleeberg, C Hassel, et al.

Journal of Cancer Research and Clinical Oncology|January 1, 1988

Phase I study of pirarubicinA A Miller, M E Scheulen, U R Kleeberg, et al.

Pageof 4